AIG
HLVX

American International Group’s HilleVax HLVX Stock Holding History

American International Group’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,921
Closed -$215K – 1197
2024
Q1 		$215K Sell
12,921
-110
-0.8% -$1.76K ﹤0.01% 2104
2023
Q4 		$209K Buy
13,031
+2,437
+23% +$32.4K ﹤0.01% 2153
2023
Q3 		$142K Buy
10,594
+378
+4% +$5.32K ﹤0.01% 2309
2023
Q2 		$176K Buy
10,216
+1,791
+21% +$27.8K ﹤0.01% 2248
2023
Q1 		$139K Buy
8,425
+167
+2% +$2.67K ﹤0.01% 2309
2022
Q4 		$138K Buy
8,258
+2,105
+34% +$38K ﹤0.01% 2358
2022
Q3 		$105K Buy
6,153
+87
+1% +$1.26K ﹤0.01% 2528
2022
Q2 		$66K Buy
+6,066
New +$72K ﹤0.01% 2780

Other funds holding HLVX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CP
Catalys Pacific Tokyo, Japan $229M AUM 100.3% 1-Year Est. Return

American International Group's HLVX Position: Q2 2024 in Review

American International Group sold out of HilleVax (HLVX) in Q2 2024, closing a stake of 12,921 shares — an estimated $215K sold.

American International Group first reported a position in HLVX in Q2 2022 and held it in 8 quarters. The position peaked at $215K in Q1 2024. 93 funds tracked by Wall St. Rank hold HLVX as of Q2 2024.

  • American International Group reported no remaining HilleVax position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 12,921 HilleVax shares in Q2 2024, an estimated $215K.
  • American International Group first reported a position in HilleVax in Q2 2022 and held it in 8 quarters.
  • American International Group's HilleVax position peaked at $215K in Q1 2024.
  • 93 funds tracked by Wall St. Rank held HilleVax as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.